Pharnext SA (OTCMKTS:PNEXF – Get Rating)’s stock is going to reverse split on Wednesday, May 10th. The 1-10000 reverse split was announced on Wednesday, May 10th. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, May 10th. Pharnext Price Performance Pharnext has a fifty-two week low of $0.00 […]
PARIS, France, April 18th, 2023, 08:30 am CET – Pharnext SA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with. | April 18, 2023
PARIS, France, April 18th, 2023, 08:30 am CET - Pharnext SA (FR001400BV89 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative
March 22-24: 26th Congress of the Medical-Scientific Advisory Committee of the German Society for Myopathic Patients (DGM), followed by a patient Day on March 25th, both held in Essen, Germany March
Thursday, March 17th: "Innovative therapies in CMT", Thematic Day organized by FILNEMUS, the Rare Diseases Network dedicated to neuromuscular diseases. Friday, March 18th: 32nd annual meeting of